Home › Celiac Disease › NCT02061306

Celiac Disease Genomic Environmental Microbiome and Metabolomic Study

Celiac Disease Genomic Environmental Microbiome and Metabolomic (CDGEMM) Study

Who can join

6 Months · All sexes

Inclusion Criteria:

* Newborns and infants less than 6 months of age who have not been introduced to solid foods (exclusive breast milk or formula diet)
* First-degree relatives of patients affected with biopsy-proven CD

Exclusion Criteria:

* Infants older than 6 months of age
* Inability or unwillingness of legal guardian/representative to give written informed consent

About the study

Celiac disease (CD) is a complex disease caused by eating gluten, a protein contained in wheat, rye, and barley. It is well known that many factors contribute to the development of CD, including the genes that you have and the foods that you eat. In the CDGEMM study, we will consider as many of these factors as possible and study how they each contribute to disease development. If the investigators find that any one factor, or combination of factors, increases the risk of developing CD, we will be able to apply this information and help prevent or detect disease in high-risk children in the future.

Sponsor: Massachusetts General Hospital · Participants: 500 · Started: 2014-03

Contact the study team

• Victoria Kenyon, MHA · Phone: 617-643-4366

Official record on ClinicalTrials.gov — NCT02061306

Locations in the U.S.

Conditions

• Celiac Disease

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.